Lupus Ventures Information

Lupus Ventures is a venture capital and private equity fund dedicated to advancing treatment and diagnostic options for systemic lupus erythematosus (SLE), its manifestations, and related autoimmune conditions. We seek to be a value-add investor with deep domain expertise, and define success as improving the standard of care and delivering meaningful value to the millions of people living with lupus worldwide. The Fund is an affiliate of the Lupus Research Alliance (www.lupusresearch.org), the world’s largest private funder of lupus research. The Lupus Research Alliance has awarded more than $284 million across 650+ research grants, and clinical affiliate Lupus Therapeutics is involved in more than 25% of all active clinical trials.